Finance

Lists
300529:SHE
Jafron Biomedical Co Ltd
CNÂ¥15.90
0.00%
(0.00) 1D
Aug 28, 3:04:46 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300529...
Open
CNÂ¥15.91
High
CNÂ¥15.94
Low
CNÂ¥15.80
Mkt. cap
12.70B
Avg. vol.
9.81M
Volume
4.40M
Dividend
3.27%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jun 1, 2026
P/E ratio
23.74
52-wk high
CNÂ¥24.66
52-wk low
CNÂ¥14.73
EPS
CNÂ¥0.67
Shares outstanding
798.61M
No. of employees
2K
Open
CNÂ¥15.91
High
CNÂ¥15.94
Low
CNÂ¥15.80
Mkt. cap
12.70B
Avg. vol.
9.81M
Volume
4.40M
Dividend
3.27%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jun 1, 2026
P/E ratio
23.74
52-wk high
CNÂ¥24.66
52-wk low
CNÂ¥14.73
EPS
CNÂ¥0.67
Shares outstanding
798.61M
No. of employees
2K
About Jafron Biomedical Co Ltd
CEO-
Employees2.2K
FoundedDec 19, 1989
Headquarters-
SectorMedical device
Websitejafron.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
421.61M
455.80M
560.62M
471.85M
Cost of goods sold
82.44M
122.83M
127.54M
110.75M
Cost of revenue
82.44M
122.83M
127.54M
110.75M
Research and development expenses
49.57M
51.42M
45.69M
57.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
172.41M
135.77M
115.42M
117.22M
Operating expense
226.42M
197.92M
166.90M
187.46M
Total operating expenses
308.86M
320.75M
294.44M
298.21M
Operating income
112.74M
135.05M
266.18M
173.64M
Other non operating income
-2.81M
3.02M
-1.18M
325.24K
EBT including unusual items
90.15M
108.07M
260.01M
187.12M
EBT excluding unusual items
100.80M
171.31M
258.91M
167.29M
Income tax expense
26.96M
28.26M
39.37M
24.78M
Effective tax rate
29.91%
26.15%
15.14%
13.24%
Other operating expenses
7.07M
8.52M
4.18M
13.61M
Net income
63.51M
79.59M
220.51M
161.46M
Net profit margin
15.06%
17.46%
39.33%
34.22%
Earnings per share
-
-
-
-
Interest and investment income
3.94M
48.69M
6.26M
9.06M
Interest expense
-13.41M
-13.28M
-12.35M
-12.43M
Net interest expenses
-9.47M
35.41M
-6.09M
-3.37M
Depreciation and amortization charges
-
-
-
-
EBITDA
143.16M
164.34M
295.47M
203.48M
Gain or loss from assets sale
-1.41M
79.85K
-
-113.20K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps